Explore Watchlists Pricing

WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) Balance sheet

Market cap

¥11.8B

P/E ratio

51.4x

Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	2,572	2,521	3,611	3,849	3,262	2,884	2,844	3,232	3,879	3,665	2,955	2,006
Marketable securities, current	-	406	407	-	-	-	-	-	-	-	-	-	-
Inventories	-	1,268	1,745	1,530	1,295	1,380	1,411	1,067	1,250	990	1,031	1,964	2,619
Total current assets	-	9,686	9,559	9,789	9,899	9,625	8,648	7,638	8,608	9,353	8,970	8,908	9,672
Property, plant and equipment, net	-	5,062	4,764	4,224	4,059	3,907	3,648	3,527	3,297	3,032	3,028	3,313	3,662
Marketable securities, non-current	-	2,864	2,722	2,595	2,825	2,634	2,411	2,466	2,066	2,483	2,442	1,848	2,253
Total non-current assets	-	9,285	8,724	8,099	8,056	8,139	7,335	6,934	6,345	6,358	6,451	6,094	6,828
Total assets	-	18,971	18,283	17,888	17,955	17,764	15,983	14,572	14,953	15,712	15,421	15,003	16,500
Short-term debt	-	308	428	260	260	140	100	100	100	100	100	100	100
Long-term debt, current	-	-	-	-	-	-	-	-	-	-	-	-	38
Total current liabilities	-	2,667	2,571	2,467	2,414	2,709	2,435	1,713	2,009	2,239	1,808	2,035	2,781
Total non-current liabilities	-	2,180	1,758	1,525	1,433	1,294	1,602	1,474	1,464	1,566	1,587	1,358	1,710
Total liabilities	-	4,847	4,329	3,992	3,848	4,003	4,036	3,187	3,473	3,805	3,395	3,392	4,491
Retained earnings	-	6,953	6,869	6,860	6,882	6,596	4,940	4,338	4,568	4,706	4,711	4,672	4,795
Stockholders' equity	13,813	14,124	13,955	13,897	14,107	13,761	11,947	11,386	11,481	11,907	12,026	11,610	12,009